| Greetings!
Most clinical trials are still stuck in the past… built on restrictive designs that slow enrollment, exclude real patients, and waste years chasing data that regulators no longer find convincing. The FDA has made it clear: the old way of writing protocols and running studies is not enough anymore.
This masterclass takes you inside the new framework. It’s not theory… it’s a practical walk through how to move from outdated rules to modern, inclusive, patient-centric trials. You’ll see how to replace rigid eligibility criteria with defensible language, how to use decentralized components and real-world evidence to expand reach, and how to run operations and QA in a way that avoids busywork while staying fully compliant. The goal is simple… smarter trials that regulators trust and patients actually benefit from.
Leading the session is Dr. Tigran Uzunyan, a medical doctor and research scientist with nearly two decades of experience in clinical development. From early-phase studies and bioequivalence trials to large late-phase programs across multiple jurisdictions, he has seen where traditional models fail and how modern strategies succeed. His work spans everything from pharmacology research to medical cannabis development in Canada, making his perspective both global and deeply practical.
If you are responsible for trial design, operations, QA, or regulatory strategy, this session will give you what you need to move beyond the checklists and into the real future of clinical trials. The question is… are you ready to let go of outdated trial designs, or will you risk falling behind? | 
No comments:
Post a Comment